Unknown

Dataset Information

0

Efficient Selection of Recombinant Fluorescent Vaccinia Virus Strains and Rapid Virus Titer Determination by Using a Multi-Well Plate Imaging System.


ABSTRACT: Engineered vaccinia virus (VACV) strains are used extensively as vectors for the development of novel cancer vaccines and cancer therapeutics. In this study, we describe for the first time a high-throughput approach for both fluorescent rVACV generation and rapid viral titer measurement with the multi-well plate imaging system, IncuCyte®S3. The isolation of a single, well-defined plaque is critical for the generation of novel recombinant vaccinia virus (rVACV) strains. Unfortunately, current methods of rVACV engineering via plaque isolation are time-consuming and laborious. Here, we present a modified fluorescent viral plaque screening and selection strategy that allows one to generally obtain novel fluorescent rVACV strains in six days, with a minimum of just four days. The standard plaque assay requires chemicals for fixing and staining cells. Manual plaque counting based on visual inspection of the cell culture plates is time-consuming. Here, we developed a fluorescence-based plaque assay for quantifying the vaccinia virus that does not require a cell staining step. This approach is less toxic to researchers and is reproducible; it is thus an improvement over the traditional assay. Lastly, plaque counting by virtue of a fluorescence-based image is very convenient, as it can be performed directly on the computer.

SUBMITTER: Ye M 

PROVIDER: S-EPMC8393244 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC2925039 | biostudies-literature
| S-EPMC4224325 | biostudies-literature
| S-EPMC9491075 | biostudies-literature
| 2109815 | ecrin-mdr-crc
| S-EPMC2704791 | biostudies-literature
| S-EPMC8503571 | biostudies-literature
| S-EPMC4300770 | biostudies-literature
| PRJNA290292 | ENA
| PRJNA238138 | ENA
| PRJNA169009 | ENA